Todd Harris
Förmögenhet: 34 M $ per 2026-08-31
Förmögenhet: 34 M $ per 2026-08-31
Todd J.
Harris is the founder of Tyra Biosciences, Inc., founded in 2018, holding the titles of President, CEO, Treasurer & Director.
Dr. Harris was the founder of Sienna Biopharmaceuticals, Inc., founded in 2010, holding the titles of Director & Head-Corporate Development from 2016 to 2018.
Dr. Harris currently holds the position of Director at Primmune Therapeutics, Inc. since 2019.
Dr. Harris's education includes a doctorate from Massachusetts Institute of Technology, graduate studies at the University of California San Diego, and an undergraduate degree from Brigham Young University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC 2,28 % | 2026-05-05 | 1 358 631 ( 2,28 % ) | 34 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Grundare | 2018-08-02 |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Direktör/Styrelseledamot | 2019-10-01 |
| Företag | Position | Slut |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Grundare | 2018-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Commercial Services |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån